Trial Profile
A Retrospective,Cohort study to evaluate the efficacy and safety of Trabectedin in patients with recurrent soft tissue sarcoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Nov 2016
Price :
$35
*
At a glance
- Drugs Trabectedin (Primary)
- Indications Soft tissue sarcoma
- Focus Adverse reactions; Therapeutic Use
- 14 Nov 2016 New trial record